Rukiye Arıkan

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

Özkan Alan, Tuğba Akın Telli, Bilge Aktaş et al. · World Journal of Surgical Oncology · 2020 · 32 citations · Full text

Medicine, Endocrinology, Oncology +14

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer

Seval Ay, Muhammed Mustafa Atçı, Rukiye Arıkan et al. · Journal of Chemotherapy · 2022 · 17 citations

Medicine, Oncology, Pharmacology +13

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

Nazım Can Demircan, Özkan Alan, Tuğba Başoğlu et al. · Journal of Oncology Pharmacy Practice · 2019 · 15 citations

Pharmacy, Oncology, Pharmacotherapy +17

Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma

Özlem Erçelep, Özkan Alan, Tuğba Akın Telli et al. · Tumori Journal · 2020 · 13 citations

Medicine, Oncology, Radiology +17

PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Okan Avcı, Yakup İriağaç, Eyyüp Çavdar et al. · Journal of Geriatric Oncology · 2023 · 12 citations · Full text

Medicine, Oncology, Pharmacology +10